Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL)

Journal of Hematology and Oncology

Volumn 5, Issue , 2012, Pages

  Kim, Yu Ri ^a   Kim, Jin Seok ^a,o   Min, Yoo Hong ^a   Hyunyoon, Dok ^b   Shin, Ho Jin ^c   Mun, Yeung Chul ^d   Park, Yong ^e   Do, Young Rok ^f   Jeong, Seong Hyun ^g   Park, Joon Seong ^g   Oh, Sung Yong ^h   Lee, Suee ^h   Park, Eun Kyung ⁱ   Jang, Joung Soon ⁱ   Lee, Won Sik ^j   Lee, Hwe Won ^k   Eom, Hyeonseok ^k   Ahn, Jae Sook ^l   Jeong, Jae Heon ^m   Baek, Sun Kyung ^m   Kim, Seok Jin ⁿ   Kim, Won Seog ⁿ   Suh, Cheolwon ^b   more..

^a Yonsei University   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Pusan National University School of Medicine   (South Korea)

^d Ewha Womans University School of Medicine   (South Korea)

^e Korea University College of Medicine   (South Korea)

^f Keimyung University   (South Korea)

^g Ajou University School of Medicine   (South Korea)

^h Dong A University   (South Korea)

ⁱ Chung Ang University College of Medicine   (South Korea)

^j Inje University College of Medicine   (South Korea)

^k National Cancer Center   (South Korea)

^l Chonnam National University Research Institute of Medical Sciences   (South Korea)

^m Kyung Hee University College of Medicine   (South Korea)

ⁿ Samsung Medical Center   (South Korea)

^o Yonsei University College of Medicine   (South Korea)

more..

Author keywords

Diffuse large B cell lymphoma; Primary adrenal lymphoma; Prognostic factor; R CHOP

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADRENAL TUMOR; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; HUMAN; LARGE CELL LYMPHOMA; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; SURVIVAL TIME;

ADULT; AGED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COHORT STUDIES; CYCLOPHOSPHAMIDE; DOXORUBICIN; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MIDDLE AGED; PREDNISONE; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; VINCRISTINE;

EID: 84864795374     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/1756-8722-5-49     Document Type: Article

References (29)

1. Primary non-Hodgkins lymphoma of bone. A clinicopathologic study. Baar J, Burkes RL, Bell R, Blackstein ME, Fernandes B, Langer F, Cancer 1994 73 1194 1199 10.1002/1097-0142(19940215)73:4<1194::AID-CNCR2820730412>3.0.CO;2-R 8313322 (Pubitemid 24061615)
2. FDG-PET imaging in primary bilateral adrenal lymphoma: a case report and review of the literature. Kumar R, Xiu Y, Mavi A, El-Haddad G, Zhuang H, Alavi A, Clin Nucl Med 2005 30 222 230 10.1097/01.rlu.0000155983.46815.1c 15764875 (Pubitemid 40396815)
3. Adrenal involvement in non-Hodgkins lymphoma: four cases and review of literature. Singh D, Kumar L, Sharma A, Vijayaraghavan M, Thulkar S, Tandon N, Leuk Lymphoma 2004 45 789 794 10.1080/10428190310001615756 15160957 (Pubitemid 38256043)
4. Primary bilateral adrenal diffuse large B-cell lymphoma demonstrating adrenal failure. Horiguchi K, Hashimoto K, Hashizume M, Masuo T, Suto M, Okajo J, Handa H, Kaneko Y, Yokoo H, Sasaki A, et al. Internal medicine (Tokyo, Japan) 2010 49 2241 2246 10.2169/internalmedicine.49.3941
5. A case of primary adrenal diffuse large B-cell lymphoma achieving complete remission with rituximab-CHOP chemotherapy. Kim KM, Yoon DH, Lee SG, Lim SN, Sug LJ, Huh J, Suh C, J Korean Med Sci 2009 24 525 528 10.3346/jkms.2009.24.3.525 19543522
6. Primary adrenal lymphoma. Grigg AP, Connors JM, Clin Lymphoma 2003 4 154 160 10.3816/CLM.2003.n.024 14715097 (Pubitemid 38128679)
7. Adrenal insufficiency caused by primary aggressive non-Hodgkins lymphoma of bilateral adrenal glands: report of a case and literature review. Hsu CW, Ho CL, Sheu WH, Harn HJ, Chao TY, Ann Hematol 1999 78 151 154 10.1007/s002770050492 10211758 (Pubitemid 29145898)
8. Bilateral primary adrenal lymphoma. Yang Y, Li Q, Pan Y, Br J Haematol 2010 150 250-250 20456360
9. Primary bilateral adrenal lymphoma associated with idiopathic thrombocytopenic purpura. Yamamoto E, Ozaki N, Nakagawa M, Kimoto M, Leuk Lymphoma 1999 35 403 408 10.3109/10428199909145746 10706466
10. Primary bilateral adrenal lymphoma relapsing as a solid cerebral mass after complete clinical remission: a case report. Mermershtain W, Liel Y, Zirkin HJ, Lupu L, Lantsberg S, Cohen Y, Am J Clin Oncol 2001 24 583 585 10.1097/00000421-200112000-00011 11801759 (Pubitemid 33131420)
11. Rituximab in the treatment of primary bilateral adrenal lymphoma with adrenal crisis. Lim KH, Chiou TY, Lin CJ, Hsieh RK, Medical oncology (Northwood, London, England) 2008 25 107 109 10.1007/s12032-007-0051-7
12. Primary extranodal non-Hodgkins lymphoma (NHL): the impact of alternative definitions tested in the Comprehensive Cancer Centre West population-based NHL registry. Krol AD, le Cessie S, Snijder S, Kluin-Nelemans JC, Kluin PM, Noordijk EM, Annals of oncology: official journal of the European Society for Medical Oncology / ESMO 2003 14 131 139 10.1093/annonc/mdg004 (Pubitemid 36150271)
13. Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group. Zucca E, Conconi A, Mughal TI, Sarris AH, Seymour JF, Vitolo U, Klasa R, Ozsahin M, Mead GM, Gianni MA, et al. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2003 21 20 27 10.1200/JCO.2003.11.141
14. Edge SBB DR, Compton CC, Fritz AG, Greene FL, Trotti A, AJCC cancer staging manual Springer 7 2010 http://openlink.ymlib.yonsei.ac.kr:8000/link.cgi? url=http://online.statref.com/document.aspx?FxId=73&DocID=1&grpalias= Yonsei. ISBN: 0387884424 9780387884424
15. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 35-2000. An 82-year-old woman with bilateral adrenal masses and low-grade fever. N Engl J Med 2000 343 1477 1483 10.1056/NEJM200011163432008 11078774
16. Adrenal insufficiency as a manifestation of disseminated non-Hodgkins lymphoma. Levy NT, Young WF, Habermann TM, Strickler JG, Carney JA, Stanson AW, Mayo Clin Proc 1997 72 818 822 10.4065/72.9.818 9294527 (Pubitemid 27382921)
17. Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe dEtude des Lymphomes de lAdulte. Feugier P, Van Hoof A, Sebban C, Solal-Celigny P, Bouabdallah R, Ferme C, Christian B, Lepage E, Tilly H, Morschhauser F, et al. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2005 23 4117 4126 10.1200/JCO.2005.09.131 (Pubitemid 46211317)
18. Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial. Peyrade F, Jardin F, Thieblemont C, Thyss A, Emile JF, Castaigne S, Coiffier B, Haioun C, Bologna S, Fitoussi O, et al. Lancet Oncol 2011 12 460 468 10.1016/S1470-2045(11)70069-9 21482186
19. Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group. Ryan G, Martinelli G, Kuper-Hommel M, Tsang R, Pruneri G, Yuen K, Roos D, Lennard A, Devizzi L, Crabb S, et al. Annals of oncology: official journal of the European Society for Medical Oncology / ESMO 2008 19 233 241 10.1093/annonc/mdm471 (Pubitemid 351201702)
20. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Rohatiner A, dAmore F, Coiffier B, Crowther D, Gospodarowicz M, Isaacson P, Lister TA, Norton A, Salem P, Shipp M, et al. Annals of oncology: official journal of the European Society for Medical Oncology / ESMO 1994 5 397 400 (Pubitemid 24159642)
21. Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkins lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: a GELA study on 974 patients. Haioun C, Besson C, Lepage E, Thieblemont C, Simon D, Rose C, Tilly H, Sonet A, Lederlin P, Attal M, et al. Groupe dEtudes des Lymphomes de lAdulte. Annals of oncology: official journal of the European Society for Medical Oncology / ESMO 2000 11 685 690 8967290
22. Incidence and risk factors of central nervous system recurrence in aggressive lymphoma-a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkins Lymphoma Study Group (DSHNHL). Boehme V, Zeynalova S, Kloess M, Loeffler M, Kaiser U, Pfreundschuh M, Schmitz N, Annals of oncology: official journal of the European Society for Medical Oncology / ESMO 2007 18 149 157 (Pubitemid 46152515)
23. Natural history of CNS relapse in patients with aggressive non-Hodgkins lymphoma: a 20-year follow-up analysis of SWOG 8516 - the Southwest Oncology Group. Bernstein SH, Unger JM, Leblanc M, Friedberg J, Miller TP, Fisher RI, Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2009 27 114 119 10.1200/JCO.2009.21.8479
24. Most primary adrenal lymphomas are diffuse large B-cell lymphomas with non-germinal center B-cell phenotype, BCL6 gene rearrangement and poor prognosis. Mozos A, Ye H, Chuang WY, Chu JS, Huang WT, Chen HK, Hsu YH, Bacon CM, Du MQ, Campo E, Chuang SS, Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc 2009 22 1210 1217
25. Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification. Fassnacht M, Johanssen S, Quinkler M, Bucsky P, Willenberg HS, Beuschlein F, Terzolo M, Mueller HH, Hahner S, Allolio B, Cancer 2009 115 243 250 10.1002/cncr.24030 19025987
26. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, Muller-Hermelink HK, Campo E, Braziel RM, Jaffe ES, et al. Blood 2004 103 275 282 10.1182/blood-2003-05-1545 14504078 (Pubitemid 38029949)
27. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkins disease: Cotswolds meeting. Lister TA, Crowther D, Sutcliffe SB, Glatstein E, Canellos GP, Young RC, Rosenberg SA, Coltman CA, Tubiana M, Journal of clinical oncology: official journal of the American Society of Clinical Oncology 1989 7 1630 1636 (Pubitemid 19272832)
28. A predictive model for aggressive non-Hodgkins lymphoma. The International Non-Hodgkins Lymphoma Prognostic Factors Project. N Engl J Med 1993 329 987 994 8141877
29. Report of an international workshop to standardize response criteria for non-Hodgkins lymphomas. Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM, Lister TA, Vose J, Grillo-Lopez A, Hagenbeek A, et al. NCI Sponsored International Working Group. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 1999 17 1244